The five-year survival rate for patients with stage IIa cervical cancer is about 60% after treatment. Cervical cancer is a malignant tumor caused by human papillomavirus infection, heredity and other factors. Stage IIa is one of the clinical stages, which represents the situation that the tumor has no paracervical infiltration and the maximum dimension of the tumor is less than 4 centimeters; it is accompanied or not accompanied by lymph node metastasis; and there is no distant metastasis. In this period, patients can be treated with surgical resection, followed by radiotherapy and other therapies. After aggressive treatment, patients can achieve a five-year survival rate of about 60%. If the patient tolerates the treatment well and is in good physical condition, the treatment outcome is relatively good. Regular checkups after surgery can reduce the recurrence rate and prolong the survival period to a certain extent. When cervical cancer occurs, it is necessary to actively consult a doctor and receive reasonable treatment under the guidance of a physician.